HUP0105469A2 - Pirroloazepineket tartalmazó gyógyászati készítmények claudicatio intermittens kezelésére - Google Patents
Pirroloazepineket tartalmazó gyógyászati készítmények claudicatio intermittens kezeléséreInfo
- Publication number
- HUP0105469A2 HUP0105469A2 HU0105469A HUP0105469A HUP0105469A2 HU P0105469 A2 HUP0105469 A2 HU P0105469A2 HU 0105469 A HU0105469 A HU 0105469A HU P0105469 A HUP0105469 A HU P0105469A HU P0105469 A2 HUP0105469 A2 HU P0105469A2
- Authority
- HU
- Hungary
- Prior art keywords
- general formula
- present
- hydrogen atom
- chemical bond
- medicinal preparations
- Prior art date
Links
- CTVOZUFKICZROL-UHFFFAOYSA-N pyrrolo[3,2-b]azepine Chemical class C1=CC=CC2=NC=CC2=N1 CTVOZUFKICZROL-UHFFFAOYSA-N 0.000 title abstract 3
- 206010022562 Intermittent claudication Diseases 0.000 title abstract 2
- 208000021156 intermittent vascular claudication Diseases 0.000 title abstract 2
- 229940126585 therapeutic drug Drugs 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 238000002360 preparation method Methods 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 239000000126 substance Substances 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 2
- 208000031104 Arterial Occlusive disease Diseases 0.000 abstract 1
- 208000000575 Arteriosclerosis Obliterans Diseases 0.000 abstract 1
- 208000033386 Buerger disease Diseases 0.000 abstract 1
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 abstract 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 208000021328 arterial occlusion Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 208000030175 lameness Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- HMIITAWYCKLAAP-UHFFFAOYSA-N pyrazolo[4,3-b]azepine Chemical class C1=CC=CN=C2C=NN=C21 HMIITAWYCKLAAP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
A találmány tárgyát gyógyászati készítmények képezik időnkéntisántítás (claudicatio intermittens), krónikus artériaelzáródás,arteriosclerosis obliterans és thromboangiitis obliterans kezelésére;amely gyógyászati készítmények hatóanyagként (I) általános képletűpirroloazepin-származékot vagy ennek gyógyászatilag megfelelő sójáttartalmazzák; az (I) általános képletben a szaggatott vonal jelentéseadott esetben jelenlévő kémiai kötés; amennyiben a szaggatott vonallaljelzett kémiai kötés jelen van, úgy X nincs jelen, amennyiben aszaggatott vonal által jelzett kémiai kötés nincs jelen, úgy Xjelentése hidrogénatom, hidroxilcsoport vagy -OR1, amelyben R1jelentése adott esetben szubsztituált alkilcsoport, Y jelentéseegyenes vagy elágazó láncú, adott esetben szubsztituált alkilcsoport;Z1 és Z2 jelentése azonos vagy eltérő, egymástól függetlenülhidrogénatom, hidroxilcsoport vagy halogénatom, és W jelentésehidrogénatom vagy metilcsoport. A fentiekben említett betegségekkezelhetők vagy enyhíthetők az (I) általános képletű pirroloazepin-származékok vagy ezek gyógyászatilag megfelelő sóinak beadásával. Atalálmány tárgyát képezi ezen kívül az (I) általános képletűpirazoloazepin-származékok vagy ezek gyógyászatilag megfelelő sóinakalkalmazása olyan gyógyászati készítmények előállítására, amelyek azidőnkénti sántítás kezelésére adhatók. Ó
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3863199 | 1999-02-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0105469A2 true HUP0105469A2 (hu) | 2002-05-29 |
| HUP0105469A3 HUP0105469A3 (en) | 2003-01-28 |
Family
ID=12530599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0105469A HUP0105469A3 (en) | 1999-02-17 | 2000-02-17 | Therapeutic drugs comprising pyrroloazepines for treating intermittent claudication |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6288056B1 (hu) |
| EP (1) | EP1071427B1 (hu) |
| JP (1) | JP2002537259A (hu) |
| KR (1) | KR20010042658A (hu) |
| CN (1) | CN1201740C (hu) |
| AT (1) | ATE269704T1 (hu) |
| AU (1) | AU2572400A (hu) |
| CA (1) | CA2329524A1 (hu) |
| DE (1) | DE60011711T2 (hu) |
| ES (1) | ES2220396T3 (hu) |
| HU (1) | HUP0105469A3 (hu) |
| IL (1) | IL139064A0 (hu) |
| WO (1) | WO2000048602A1 (hu) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11193290A (ja) | 1997-12-26 | 1999-07-21 | Suntory Ltd | ピロールスルホンアミド系化合物 |
| KR100677594B1 (ko) * | 2005-06-10 | 2007-02-02 | 삼성전자주식회사 | 반도전성 벨트, 그 제조방법, 및 상기 반도전성 벨트를포함하는 전자사진 화상형성장치 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0525128A (ja) * | 1990-05-11 | 1993-02-02 | Suntory Ltd | ピロロアゼピン誘導体の製造方法 |
| IL121432A (en) * | 1995-12-01 | 2000-09-28 | Suntory Ltd | Pyrrolo [3,2-C]azepine-4-one derivatives and pyrrolo [3,4-C]azepine-4-one derivatives their preparation and pharmaceutical compositions containing them |
-
2000
- 2000-02-17 EP EP00903994A patent/EP1071427B1/en not_active Expired - Lifetime
- 2000-02-17 DE DE60011711T patent/DE60011711T2/de not_active Expired - Fee Related
- 2000-02-17 WO PCT/JP2000/000883 patent/WO2000048602A1/en not_active Application Discontinuation
- 2000-02-17 CN CNB008003645A patent/CN1201740C/zh not_active Expired - Fee Related
- 2000-02-17 JP JP2000599394A patent/JP2002537259A/ja active Pending
- 2000-02-17 KR KR1020007011357A patent/KR20010042658A/ko not_active Application Discontinuation
- 2000-02-17 AT AT00903994T patent/ATE269704T1/de not_active IP Right Cessation
- 2000-02-17 HU HU0105469A patent/HUP0105469A3/hu unknown
- 2000-02-17 ES ES00903994T patent/ES2220396T3/es not_active Expired - Lifetime
- 2000-02-17 IL IL13906400A patent/IL139064A0/xx unknown
- 2000-02-17 AU AU25724/00A patent/AU2572400A/en not_active Abandoned
- 2000-02-17 US US09/673,514 patent/US6288056B1/en not_active Expired - Fee Related
- 2000-02-17 CA CA002329524A patent/CA2329524A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000048602A1 (en) | 2000-08-24 |
| IL139064A0 (en) | 2001-11-25 |
| HUP0105469A3 (en) | 2003-01-28 |
| EP1071427B1 (en) | 2004-06-23 |
| CA2329524A1 (en) | 2000-08-24 |
| ES2220396T3 (es) | 2004-12-16 |
| DE60011711T2 (de) | 2005-07-07 |
| CN1201740C (zh) | 2005-05-18 |
| ATE269704T1 (de) | 2004-07-15 |
| CN1297351A (zh) | 2001-05-30 |
| US6288056B1 (en) | 2001-09-11 |
| AU2572400A (en) | 2000-09-04 |
| DE60011711D1 (de) | 2004-07-29 |
| EP1071427A1 (en) | 2001-01-31 |
| KR20010042658A (ko) | 2001-05-25 |
| JP2002537259A (ja) | 2002-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY134422A (en) | Platinum derivative pharmaceutical formulations. | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| AU2003240680A8 (en) | 1h-imidazo(4,5-c) quinoline derivatives in the treatment of protein kinase dependent diseases | |
| DE60128258D1 (de) | Indanylderivate zur Behandlung von Atemwegserkrankungen | |
| RU2006109467A (ru) | Способы лечения рака с использованием ингибиторов hdac | |
| ATE485821T1 (de) | Ophthalmologische zubereitung enthaltend roflumilast in der behandlung von krankheiten der augen | |
| CY1107838T1 (el) | Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων | |
| DE60222137D1 (de) | Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen | |
| DE60022021D1 (de) | Zubereitungen enthaltend Apomorphin und Sildenafil und ihre Verwendung zur Behandlung von erektiler Dysfunktion | |
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| CY1106763T1 (el) | Προληπτικα ή θεραπευτικα μεσα για φλεγμονωδεις νοσους του εντερου | |
| SE9901573D0 (sv) | New compounds | |
| NO20024646D0 (no) | Kombinasjonsterapier med vaskul¶r-skadende aktivitet | |
| HUP0203716A2 (hu) | Tumorellenes hatású szubsztituált (N-benzil-indol-3-il)-glioxilsav-származékok, ezeket tartalmazó gyógyszerkészítmények | |
| MD523G2 (ro) | Derivaţi noi ai triazolpirimidinei, antagonişti ai receptorilor angiotensinei II, procedee de preparare a lor, compoziţii farmaceutice ce le conţin | |
| HUP0202745A2 (hu) | Profilaktikus és terápiás szerek szembetegségek kezelésére | |
| SE0102440D0 (sv) | New compound | |
| DK1039900T3 (da) | Farmaceutisk præparat indeholdende sibutramin og orlistat | |
| RU2001118854A (ru) | Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний | |
| SE9901572D0 (sv) | New compounds | |
| HUP0105469A2 (hu) | Pirroloazepineket tartalmazó gyógyászati készítmények claudicatio intermittens kezelésére | |
| EE200200549A (et) | Jagatud doosi teraapia veresooni kahjustava aktiivsusega | |
| HUP0301408A2 (hu) | Szulodexid alkalmazása diabetikus vesebetegség kezelésére szolgáló orális gyógyszerkészítmény előállítására | |
| ATE331523T1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion | |
| KR930702985A (ko) | 식도암의 치료 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |